3382 Results

People

  1. Hudis
    Hudis
  2. Soslow
    Soslow
  3. Gonen
    Gonen
  4. Ladanyi
    Ladanyi
  5. Motzer
    Motzer
  6. Rusch
    Rusch
  7. Patil
    Patil
  8. Barakat
    Barakat
  9. Kris
    Kris
  10. Scher
    Scher

Groups

  1. Department of Medicine (1176)
  2. Surgery (803)
  3. GSK Faculty (796)
  4. Solid Tumor Oncology Division (659)
  5. Sloan Kettering Institute Faculty (606)
  6. Survivorship Research (542)
  7. Department of Pathology and Laboratory Medicine (408)
  8. Center for Hematologic Malignancies (395)
  9. Epidemiology and Biostatistics (369)
  10. Hematologic Malignancies, Division of (342)
  1. "2011"
Formats
  1. Journal Article (2141)
  2. Meeting Abstract (988)
  3. Book Section (224)
  4. Conference Paper (18)
  5. Book Whole (11)
Groups
  1. Department of Medicine (1176)
  2. Surgery (803)
  3. GSK Faculty (796)
  4. Solid Tumor Oncology Division (659)
  5. Sloan Kettering Institute Faculty (606)
  6. Survivorship Research (542)

More Groups

People
  1. Robert Soslow (64)
  2. Clifford Hudis (60)
  3. Mithat Gonen (54)
  4. Marc Ladanyi (52)
  5. Robert Motzer (52)
  6. Valerie Rusch (47)

More People

Years
  1. 2011 (3382)
Publications
  1. Journal of Clinical Oncology (319)
  2. Blood (147)
  3. Cancer Research (122)
  4. International Journal of Radiation Oncology, Biology, Physics (104)
  5. Modern Pathology (70)
  6. Laboratory Investigation (65)

More Publications

Publishers
  1. Elsevier Inc. (450)
  2. American Society of Clinical Oncology (327)
  3. Springer (231)
  4. American Association for Cancer Research (180)
  5. Nature Publishing Group (157)
  6. Wiley Blackwell (154)

More Publishers

Results (3382)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sorafenib (SOR) plus chemotherapy (CRx) for patients (pts) with advanced (adv) breast cancer (BC) previously treated with bevacizumab (BEV)
    Meeting Abstract

    Hudis, C.; Tauer, K. W.; Hermann, R. C.; Makari-Judson, G.; Isaacs, C.; Beck, J. T.; Kaklamani, V. G.; Stepanski, E. J.; Rugo, H. S.; Wang, W.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response and protracted stable disease observed in adenocarcinoma
    Meeting Abstract

    Ilson, D.; Janjigian, Y. Y.; Shah, M. A.; Kelsen, D. P.; Tang, L. H.; Campbell, J.; Fuqua, L.; Capanu, M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase I, open-label, dose-escalation study of AZD7762 in combination with irinotecan (irino) in patients (pts) with advanced solid tumors
    Meeting Abstract

    Ho, A. L.; Bendell, J. C.; Cleary, J. M.; Schwartz, G. K.; Burris, H. A.; Oakes, P.; Agbo, F.; Barker, P. N.; Senderowicz, A. M.; Shapiro, G.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Hepatic arterial infusion (HAI) in the treatment of breast cancer with liver metastases (BCLM) in patients (pts) who progressed after hormonal and systemic chemotherapy (CTx)
    Meeting Abstract

    Herran, L. A.; Jhaveri, K. L.; Seidman, A. D.; Patel, D.; Gewirtz, A. N.; Kemeny, N. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Eribulin mesylate (halichondrin B analog E7389) in platinum-sensitive ovarian cancer: A phase II study, CTEP #7431
    Meeting Abstract

    Hensley, M. L.; Kravetz, S. J.; Jia, X.; Tew, W. P.; Pereira, L.; Sabbatini, P.; Whalen, C.; Aghajanian, C.; Zarwan, C.; Berlin, S. T.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Correlates of contralateral prophylactic mastectomy in a population-based sample
    Meeting Abstract

    Hawley, S. T.; Jagsi, R.; Morrow, M.; Katz, S. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Physician preferences and knowledge gaps regarding the care of childhood cancer survivors: A survey of the American Academy of Family Physicians (AAFP)
    Meeting Abstract

    Henderson, T. O.; Nathan, P. C.; Kigin, M.; Hlubocky, F. J.; Wroblewski, K.; Stewart, T. V.; Galliher, J. M.; Oeffinger, K. C.; Daugherty, C.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Cyclin D1 and p57 expression in advanced ovarian epithelial carcinoma: A GOG study
    Meeting Abstract

    Hill, E.; Brady, W.; Birrer, M. J.; Darcy, K. M.; McGuire, W. P.; Hoskins, W. J.; Warshal, D. P.; Drake, R. D.; Hanjani, P.; Hurteau, J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Complete responses (CR/CRu) on a phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma (R/R PTCL)
    Meeting Abstract

    Horwitz, S. M.; Coiffier, B.; Foss, F. M.; Prince, H. M.; Sokol, L.; Greenwood, M.; Caballero, D.; Borchmann, P.; Morschhauser, F.; Wilhelm, M.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • FLAIR, T1 contrast enhancement, MR perfusion, and FDG PET following hypofractionated stereotactic radiotherapy (HFSRT), bevacizumab (BEV), and temozolomide (TMZ) for glioblastoma (GBM)
    Meeting Abstract

    Grommes, C.; Karimi, S.; Beal, K.; Chan, T. A.; Abrey, L. E.; Gutin, P. H.; Omuro, A. M. P.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save